SCHEMBL30261997

CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O

nearest known ligand 0.60

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR1	P32241	7/20	0.60

▸	VIPR2	P41587	8/20	0.60

▸	ECE1	P42892	1/20	0.51

▸	GLP1R	P43220	1/20	0.51

▸	MUS81	Q96NY9	1/20	0.51

▸	RXFP1	Q9HBX9	1/20	0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30262127	0.93	VIPR1 (0.60)	VIPR1VIPR2ECE1GLP1RMUS81
SCHEMBL30662325	0.93	VIPR1 (0.58)	VIPR1VIPR2RXFP1
SCHEMBL29623995	0.92	VIPR1 (0.61)	VIPR1VIPR2ECE1GLP1RMUS81
SCHEMBL29694507	0.92	VIPR2 (0.56)	VIPR1VIPR2RXFP1
SCHEMBL31603938	0.91	VIPR1 (0.58)	VIPR1VIPR2ECE1GLP1RMUS81
SCHEMBL30712884	0.91	VIPR1 (0.57)	VIPR1VIPR2RXFP1
SCHEMBL29453337	0.90	VIPR2 (0.54)	VIPR1VIPR2
SCHEMBL30183026	0.90	VIPR2 (0.55)	VIPR1VIPR2
SCHEMBL30512534	0.90	RXFP1 (0.51)	VIPR1VIPR2ECE1GLP1RMUS81
SCHEMBL30567430	0.90	TFPI (0.60)	VIPR1VIPR2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230040544-A1	COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC)	SAREPTA THERAPEUTICS, INC.	2023-02-09	—	—	US	disclosed